
    
      All patients with ST-segment elevation AMI admitted within 12 hours from symptoms onset will
      be screened to enter in this study. Data of patients with ST-segment elevation AMI within 12
      hours from symptoms onset who do not meet the inclusion criteria or do not sign the informed
      consent form are entered into a dedicated registry.
    
  